Arctic Glacier Issues Default Status Report Pursuant to National Policy 12-203
WINNIPEG, Manitoba, Nov. 05, 2018 (GLOBE NEWSWIRE) — Arctic Glacier Income Fund (CSE: AG.UN) (the “Fund”) is providing a default […]
Canadian Metals appoints new member to the board of directors and granting of stock options
MONTREAL, Nov. 05, 2018 (GLOBE NEWSWIRE) — Canadian Metals Inc. (The “Corporation”) (CSE : CME) is pleased to announce the appointment […]
ePlay Digital and Datable Announce Letter of Intent (LOI) for Software Licensing Agreement and Joint Venture
In-game product placement and location-based activation merge in the new partnership. LOS ANGELES, Nov. 05, 2018 (GLOBE NEWSWIRE) — ePlay […]
Golden Leaf Holdings Reports Fiscal Third Quarter 2018 Results
TORONTO, Nov. 05, 2018 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis […]
Liht Cannabis Corp. CEO Discusses Their Unique Tech Approach to the Cannabis Market with Uptick Newswire’s Stock Day Podcast
KELOWNA, British Columbia and PHOENIX, Nov. 05, 2018 (GLOBE NEWSWIRE) — Liht Cannabis Corp. (CSE: LIHT) (OTCQX: LIHTF) (FSE: 2M0) […]
Golden Leaf Holdings Launches Golden Fruit Chews in Nevada
PORTLAND. Ore., Nov. 05, 2018 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a […]
Biome Grow gibt Liefer- und Produktionsabkommen mit der Provinz Neufundland und Labrador bekannt, einschließlich Vertriebs- und Einzelhandelsdienstleistungen
Diese Vereinbarung stellt den größten Liefervertrag in den atlantischen Provinzen Kanadas dar TORONTO, Nov. 05, 2018 (GLOBE NEWSWIRE) — Biome […]
Oak Valley Community Bank Recognized as Most Active SBA 504 Lending Partner
OAKDALE, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) — Oak Valley Community Bank, a wholly owned subsidiary of Oak Valley Bancorp […]
Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar portfolio for unmet access and sustainability needs
Decision follows FDA request for additional information to complement submission for biosimilar rituximab Sandoz stands behind safety, efficacy and quality […]
Novartis data at ASH and SABCS show strength of pipeline and portfolio in hematology and oncology
Additional analysis from pivotal Phase III SOLAR-1 clinical trial studying investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) and fulvestrant in patients […]
